{"id":510525,"title":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T08:28:28.013000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html","snippet":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects June 8, 2018 Our file number: 18-104623-884 Health Canada is pleased to announce the revision of two…","rawSnapshotUrl":"/api/snapshots/raw/510525","browseUrl":"https://replay.healtharchive.ca/job-6/20260216082828/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html#ha_snapshot=510525","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}